Usage of this drug is indicated in the treatment of serious bacterial infections, intraabdominal infections, urinary tract infections, gynecological infections, acute pelvic infections, and surgical site infections.

Mild to moderate side effects have been observed. Side effects such as nausea, vomiting, diarrhea, a burning sensation, discoloration of the skin, soreness, a skin rash, inflammation, and blistering. Rare side effects include abdominal pain or stomach cramps and tightness in the chest.

This drug is to be prescribed cautiously in patients with hepatic disorders or renal dysfunction.

Ertapenem is contraindicated in patients with hypersensitivity to any of the constituents of this drug or who are allergic to the beta-lactam class of drugs.

In adults, the usual dose consists of 500 mg administered via intramuscular injection or intravenous infusion once a day.

We have also established roots and begun this new venture in other countries as well, such as Bangladesh, Turkey, Mongolia, Nepal, and Gabon.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai